Canada Europe Germany UK France Spain Italy Switzerland Rest of Europe Asia Pacific China Japan India Australia South Korea Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin America Middle East & Africa South Africa Saudi Arabia Rest of Middle East & Africa Table of Contents Chapter 1 Methodology & Scope Chapter 2 Executive Summary Chapter 3 Industry Insights Chapter 4 Competitive Landscape, 2022 Chapter 5 Market Estimates and Forecast, By Drug Class (USD Million) Chapter 6 Market Estimates and Forecast, By Route of Administration (USD Million) Chapter 7 Market Estimates and Forecast, By Application (USD Million) Chapter 8 Market Estimates and Forecast, By Distribution Channel (USD Million) Chapter 9 Market Estimates and Forecast, By Region (USD Million) Chapter 10 Company Profiles Don't see your key competitors
Advirti que el sector del alcohol tambin est bajo presin en el mismo sentido, tanto en los supermercados como en los restaurantes
Age, weight, and sex are meaningful modifiers of IGE risk
Yang Y, Zhou Y, Wang Y, Wei X, Wang T, Ma A
J.ZuchmanR.ZivT.HorwitzB
"Through our technology, we're dramatically reducing the cost of high-quality care -- making it easier to check your insurance and find the best treatment option -- so that as many patients as possible can achieve their weight loss goals." Ro's obesity care formulary is one the most comprehensive of any telehealth company, integrating branded cash pay and insurance-eligible options that can be picked up at a retail pharmacy or delivered to one's home